| lurasidone / Generic mfg. |
OC-DDI, NCT00549666: A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects |
|
|
| Completed | 1 | 23 | US | Lurasidone 40 mg, Placebo 40 mg, Ortho Tri-Cyclen | Sunovion | Pharmacokinetics | 12/07 | 12/07 | | |
NCT01082146: RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE |
|
|
| Completed | 1 | 6 | US | Lurasidone | Sunovion | Pharmacokinetics, Metabolism | 08/08 | 08/08 | | |
NCT01082276: Rifampin Drug-Drug Interaction Study With Lurasidone HCl |
|
|
| Completed | 1 | 20 | US | Lurasidone HCl | Sunovion | Male, Healthy Normal Subjects | 08/08 | 08/08 | | |
NCT01082250: The Bioequivalence Of Two Different Lurasidone Formulations In Patients |
|
|
| Completed | 1 | 52 | US | Lurasidone HCl | Sunovion | Schizophrenia | 09/08 | 09/08 | | |
NCT01074073: Lithium Drug-Drug Interaction Study With Lurasidone HCl |
|
|
| Completed | 1 | 24 | US | Lurasidone HCl | Sunovion | Schizophrenia | 10/08 | 10/08 | | |
NCT01082289: Digoxin Drug-Drug Interaction With Lurasidone HCl |
|
|
| Completed | 1 | 24 | US | Lurasidone | Sunovion | Schizophrenia | 10/08 | 10/08 | | |
NCT01082263: Midazolam Drug-Drug Interaction Study With Lurasidone HCl |
|
|
| Completed | 1 | 24 | US | Lurasidone HCl | Sunovion | Schizophrenia Patients | 11/08 | 11/08 | | |
NCT01074632: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl |
|
|
| Completed | 1 | 26 | US | Lurasidone HCl | Sunovion | Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | 09/09 | 09/09 | | |
| Completed | 1 | 105 | US | Lurasidone | Sunovion | Schizophrenia, Autism | 05/13 | 05/13 | | |
NCT02174510: A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects |
|
|
| Completed | 1 | 37 | RoW | 20mg lurasidone, 40mg lurasidone, 80mg lurasidone, placebo | Sumitomo Pharma (Suzhou) Co., Ltd., Xuhui Central Hospital, Shanghai | Schizophrenia | 04/14 | 04/14 | | |
NCT02174523: Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects |
|
|
| Completed | 1 | 14 | RoW | 40mg lurasidone, placebo | Sumitomo Pharma (Suzhou) Co., Ltd., Xuhui Central Hospital, Shanghai | Schizophrenia | 04/14 | 04/14 | | |
